Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Rotavirus Vaccine Market Growth From $11.19 Billion In 2026 To $16.44 Billion By 2030 At A CAGR Of 10.1%
The rotavirus vaccine market has experienced significant expansion in recent times. It will grow from $10.14 billion in 2025 to $11.2 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. Historically, this growth was influenced by factors such as a rise in pediatric gastroenteritis incidence, the expansion of national immunization programs, an increase in public health vaccination initiatives, the availability of live attenuated vaccines, and growing awareness of rotavirus prevention.
The rotavirus vaccine market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $16.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This growth during the projected timeframe stems from several factors, including a rising demand for comprehensive pediatric immunization, advancements in the development of combination vaccines, increased investments in vaccine production capabilities, a heightened emphasis on worldwide immunization reach, and strengthened partnerships with public health organizations. Key trends expected within this period encompass the broadening scope of pediatric immunization schemes, a surge in the acceptance of oral vaccine types, an intensified commitment to optimizing the vaccine cold chain, the proliferation of public health vaccination efforts, and improved monitoring of rotavirus infections.
Get A Free Sample Report With In-Depth Market Insights:
Rotavirus Vaccine Market Expansion Drivers: What’s Shaping Future Growth?
An anticipated increase in birth rates is projected to drive the expansion of the rotavirus vaccine market in the future. Birth rates quantify the count of live births per 1,000 individuals within a population during a defined timeframe, usually reported yearly. These rates are impacted by enhanced economic stability and development, along with supportive government initiatives like parental leave, child support, and subsidies for childcare. Administering rotavirus vaccines contributes to decreasing the occurrence of severe rotavirus gastroenteritis among infants, consequently enhancing children’s health and lowering medical expenditures linked to rotavirus infections. For example, in January 2023, a report from the US-based national public health entity, the Centers for Disease Control and Prevention, indicated that the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, when contrasted with the preceding year. Consequently, an increase in birth rates will stimulate the expansion of the rotavirus vaccine market.
Rotavirus Vaccine Market Segment Trends And Revenue Contributors
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Rotavirus Vaccine Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the rotavirus vaccine market are adopting oral-dosing applicators to improve vaccine delivery efficiency and enhance patient adherence. These oral-dosing applicators are medical devices specifically designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and user-friendliness, particularly for infants and young children. For example, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, and Emory University, a U.S.-based private university, initiated a first-in-human clinical trial for the inactivated rotavirus vaccine CC24, delivered using a dissolvable microarray patch. This patch is thermostable, thereby reducing dependence on the cold chain, allows for self-administration, and generates no sharps waste. This innovation holds the promise of increasing vaccine access in low-resource settings, although regulatory pathways are yet to be fully established, and risks associated with scaling up production might delay its widespread integration into the rotavirus vaccine market.
Rotavirus Vaccine Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
View The Full Rotavirus Vaccine Market Report:
Rotavirus Vaccine Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model